Cannabidiol in patients with treatment-resistant epilepsy - Authors' reply

Lancet Neurol. 2016 May;15(6):545-6. doi: 10.1016/S1474-4422(16)00120-4. Epub 2016 Apr 11.

Authors

Orrin Devinsky¹, Eric Marsh², Daniel Friedman³

Affiliations

¹ Comprehensive Epilepsy Center, New York University Langone Medical Center, New York, NY, USA. Electronic address: od4@nyu.edu.
² Departments of Neurology and Pediatrics, Division of Child Neurology, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
³ Comprehensive Epilepsy Center, New York University Langone Medical Center, New York, NY, USA.

PMID: 27302119
DOI: 10.1016/S1474-4422(16)00120-4

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticonvulsants
Cannabidiol*
Epilepsy*
Humans

Substances

Anticonvulsants
Cannabidiol